Hereditary uveal melanoma: A report of a germline mutation in BAP1

Genes Chromosomes and Cancer

Volumn 52, Issue 4, 2013, Pages 378-384

  Höiom, Veronica ^a   Edsgärd, Daniel ^b   Helgadottir, Hildur ^a   Eriksson, Hanna ^a   All Ericsson, Charlotta ^c   Tuominen, Rainer ^a   Ivanova, Ivayla ^a   Lundeberg, Joakim ^b   Emanuelsson, Olof ^b   Hansson, Johan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^c ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BAP1 PROTEIN; IPILIMUMAB; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ALLELE; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER SCREENING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ECHOOCULOGRAPHY; EXOME; EXOME SEQUENCING; EYE EXAMINATION; FAMILY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GERM LINE; HUMAN; LIVER METASTASIS; LOSS OF FUNCTION MUTATION; OPHTHALMOSCOPY; PHENOTYPE; PRIORITY JOURNAL; SYMPTOM; UVEA MELANOMA; WILD TYPE;

ADOLESCENT; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; MELANOMA; PEDIGREE; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE; UVEAL NEOPLASMS;

EID: 84873725170     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22035     Document Type: Article

References (21)

1. Abdel-Rahman MH, Pilarski R, Ezzat S, Sexton J, Davidorf FH. 2010. Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma. Fam Cancer 9: 431-438.
2. Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, Hovland P, Davidorf FH. 2011. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 48: 856-859.
3. Buchhagen DL, Qiu L, Etkind P. 1994. Homozygous deletion, rearrangement and hypermethylation implicate chromosome region 3p14.3-3p21.3 in sporadic breast-cancer development. Int J Cancer 57: 473-479.
4. COMS. 2001. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol 119: 670-676.
5. Danielli R, Ridolfi R, Chiarion-Sileni V, Queirolo P, Testori A, Plummer R, Boitano M, Calabro L, Rossi CD, Giacomo AM, Ferrucci PF, Ridolfi L, Altomonte M, Miracco C, Balestrazzi A, Maio M. 2011. Ipilimumab in pretreated patients with metastatic uveal melanoma: Safety and clinical efficacy. Cancer Immunol Immunother 61: 41-48.
6. Flejter WL, Li FP, Antman KH, Testa JR. 1989. Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: Possible sites of tumor suppressor genes. Genes Chromosomes Cancer 1: 148-154.
7. Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM. 2010. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330: 1410-1413.
8. Houlston RS, Damato BE. 1999. Genetic predisposition to ocular melanoma. Eye (Lond) 13 ( Part 1): 43-46.
9. Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, Ishov AM, Tommerup N, Vissing H, Sekido Y, Minna J, Borodovsky A, Schultz DC, Wilkinson KD, Maul GG, Barlev N, Berger SL, Prendergast GC, Rauscher FJIII. 1998. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16: 1097-1112.
10. Jonsson G, Bendahl PO, Sandberg T, Kurbasic A, Staaf J, Sunde L, Cruger DG, Ingvar C, Olsson H, Borg A. 2005. Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32. J Natl Cancer Inst 97: 1377-1382.
11. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. 2009. The sequence alignment/map format and SAMtools. Bioinformatics 25: 2078-2079.
12. Lu YY, Jhanwar SC, Cheng JQ, Testa JR. 1994. Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma. Genes Chromosomes Cancer 9: 76-80.
13. Murthy SS, Testa JR. 1999. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J Cell Physiol 180: 150-157.
14. Naus NC, van Drunen E, de Klein A, Luyten GP, Paridaens DA, Alers JC, Ksander BR, Beverloo HB, Slater RM. 2001. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization. Genes Chromosomes Cancer 30: 267-273.
15. Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H. 2012. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One 7: e35295.
16. Shah CP, Weis E, Lajous M, Shields JA, Shields CL. 2005. Intermittent and chronic ultraviolet light exposure and uveal melanoma: A meta-analysis. Ophthalmology 112: 1599-1607.
17. Singh AD, Wang MX, Donoso LA, Shields CL, De Potter P, Shields JA. 1996. Genetic aspects of uveal melanoma: A brief review. Semin Oncol 23: 768-772.
18. Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M. 2011. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43: 1022-1025.
19. Wang K, Li M, Hakonarson H. 2010. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 38: e164.
20. Ventii KH, Devi NS, Friedrich KL, Chernova TA, Tighiouart M, Van Meir EG, Wilkinson KD. 2008. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res 68: 6953-6962.
21. Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rutten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR. 2011. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43: 1018-1021.